We are live on ! Find out more
GHCM

Glen Harbor Capital Management Portfolio holdings

AUM $4.82B
1-Year Est. Return 4.69%
This Fund
S&P 500
This Quarter Est. Return
+4.4%
1 Year Est. Return
+4.69%
3 Year Est. Return
+49.45%
5 Year Est. Return
10 Year Est. Return
AUM
$4.79B
AUM Growth
+$135M
Cap. Flow
-$11.3M
Cap. Flow %
-0.24%
Top 10 Hldgs %
21.63%
Holding
1,353
New
51
Increased
493
Reduced
318
Closed
30

Top Sells

Rank Stock Value
1
LIN icon
Linde
LIN
+$28.9M
2
CELG
Celgene Corp
CELG
+$27.8M
3
INTC icon
Intel
INTC
+$19.4M
4
PYPL icon
PayPal
PYPL
+$11.3M
5
NKE icon
Nike
NKE
+$11.1M

Sector Composition

Rank Sector Weight
1 Technology 17.75%
2 Financials 15.97%
3 Healthcare 12.71%
4 Consumer Discretionary 10.41%
5 Industrials 10.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WVE icon
1276
Wave Life Sciences
WVE
$879M
$33K ﹤0.01%
1,260
+252
+25% +$7.07K
XLC icon
1277
State Street Communication Services Select Sector SPDR ETF
XLC
$23.1B
$32K ﹤0.01%
656
-144
-18% -$7K
OPTU
1278
Optimum Communications Inc
OPTU
$377M
$31K ﹤0.01%
1,276
-22
-2% -$522
LOVE
1279
LoveSac
LOVE
$215M
$29K ﹤0.01%
+924
New +$31.8K
MYOK
1280
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$29K ﹤0.01%
572
KGC icon
1281
Kinross Gold
KGC
$33.3B
$28K ﹤0.01%
7,672
+1,540
+25% +$5.19K
DOCU
1282
DocuSign
DOCU
$13.4B
$27K ﹤0.01%
544
-1,836
-77% -$98K
VTOL icon
1283
Bristow Group
VTOL
$1.25B
$27K ﹤0.01%
1,616
MNDT
1284
DELISTED
Mandiant, Inc. Common Stock
MNDT
$27K ﹤0.01%
1,840
ICL icon
1285
ICL Group
ICL
$7.2B
$26K ﹤0.01%
5,134
+884
+21% +$4.68K
QTWO icon
1286
Q2 Holdings
QTWO
$3.75B
$26K ﹤0.01%
336
SNDX icon
1287
Syndax Pharmaceuticals
SNDX
$1.62B
$26K ﹤0.01%
2,816
SENEA icon
1288
Seneca Foods Class A
SENEA
$1.22B
$25K ﹤0.01%
912
OBSV
1289
DELISTED
ObsEva SA Ordinary Shares
OBSV
$24K ﹤0.01%
2,142
BB icon
1290
BlackBerry
BB
$4.57B
$23K ﹤0.01%
3,248
+672
+26% +$5.83K
BOX icon
1291
Box
BOX
$4.77B
$23K ﹤0.01%
1,292
MEOH icon
1292
Methanex
MEOH
$4.99B
$23K ﹤0.01%
532
+28
+6% +$1.4K
SILK
1293
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
$23K ﹤0.01%
+484
New +$20.6K
AGIO icon
1294
Agios Pharmaceuticals
AGIO
$1.96B
$22K ﹤0.01%
442
-6,222
-93% -$333K
SGMO
1295
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$22K ﹤0.01%
+2,040
New +$21.7K
IVC
1296
DELISTED
Invacare Corporation
IVC
$21K ﹤0.01%
+3,968
New +$25.9K
AZPN
1297
DELISTED
ASPEN TECHNOLOGY INC
AZPN
$21K ﹤0.01%
168
-588
-78% -$73.5K
BBIO icon
1298
BridgeBio Pharma
BBIO
$13.4B
$20K ﹤0.01%
+748
New +$20.4K
VRNT
1299
DELISTED
Verint Systems
VRNT
$19K ﹤0.01%
691
FATE icon
1300
Fate Therapeutics
FATE
$282M
$18K ﹤0.01%
896

Similar funds

Glen Harbor Capital Management's Q2 2019 Portfolio in Review

As of Q2 2019, Glen Harbor Capital Management held 1,353 positions worth $4.79B, up 2.9% from $4.65B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Glen Harbor Capital Management's Q2 2019 filing shows 51 new, 493 increased, 318 reduced and 30 closed positions. Its largest new stake was Middleby: 9,688 shares worth $1.31M. The largest sale was Linde, an estimated $28.9M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Financials and Healthcare.

  • Glen Harbor Capital Management's largest Q2 2019 buy was Middleby: 9,688 shares worth $1.31M.
  • Glen Harbor Capital Management added most to iShares Russell 1000 Growth ETF in Q2 2019, an estimated $22.9M increase.
  • Glen Harbor Capital Management's biggest Q2 2019 reduction was Linde, cutting an estimated $28.9M.
  • Glen Harbor Capital Management fully exited Burlington in Q2 2019, selling an estimated $1.56M.
  • Glen Harbor Capital Management's ten largest holdings make up 22% of its $4.79B portfolio in Q2 2019.
  • Glen Harbor Capital Management opened 51 new positions and closed 30 in Q2 2019.
  • Glen Harbor Capital Management's portfolio value rose 2.9% quarter-over-quarter to $4.79B.

Based on Glen Harbor Capital Management's 13F filing for Q2 2019, filed 13 Aug 2019.